Table: Taiko Pharmaceutical -9-MTH group results

Taiko Pharmaceutical

10/02/2017 06:00

Feb 10 (Reuters)-  
             Taiko Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2016        Dec 31, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               6.06                6.10             8.40      
                   (-0.7 pct)          (-15.4 pct)      (+0.9 pct)   
  Operating           1.76                1.28             1.35      
                   (+37.1 pct)         (-49.3 pct)      (+0.2 pct)   
  Recurring           1.64                1.32             1.11      
                   (+24.1 pct)         (-51.9 pct)      (-15.1 pct)  
  Net                 1.25               774 mln          850 mln    
                   (+61.6 pct)         (-57.1 pct)      (+1.2 pct)   
  EPS               91.94 yen           60.21 yen        65.24 yen   
  EPS Diluted       91.05 yen           58.79 yen                    
  Ann Div                               15.00 yen        15.00 yen   
  -Q2 div              NIL                 NIL                       
  -Q4 div                               15.00 yen        15.00 yen   
   
  NOTE - Taiko Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T 
  ((Tokyo Headline News Desk +813 6441 1812))